1.Transformation into large-cell neuroendocrine carcinoma associated with acquired resistance to erlotinib in nonsmall cell lung cancer.
Jeong Uk LIM ; In Sook WOO ; Yun Hwa JUNG ; Jae Ho BYEON ; Chan Kwon PARK ; Tae Jung KIM ; Hyo Rim KIM
The Korean Journal of Internal Medicine 2014;29(6):830-833
No abstract available.
Adenocarcinoma/chemistry/*drug therapy/secondary
;
Adult
;
Antineoplastic Agents/*therapeutic use
;
Biopsy
;
Carcinoma, Large Cell/chemistry/*pathology
;
Carcinoma, Neuroendocrine/chemistry/*pathology
;
Carcinoma, Non-Small-Cell Lung/chemistry/*drug therapy/secondary
;
*Drug Resistance, Neoplasm
;
Humans
;
Lung Neoplasms/chemistry/*drug therapy/pathology
;
Magnetic Resonance Imaging
;
Male
;
Protein Kinase Inhibitors/*therapeutic use
;
Quinazolines/*therapeutic use
;
Tomography, X-Ray Computed
;
Treatment Outcome
;
Tumor Markers, Biological/analysis